PURPOSE: To obtain a drug preparation for transcutaneous absorption having the stability as well as good transcutaneous absorbability of nicorandil by uniformly dispersing nicorandil in a base agent in the form of fine crystal particles having specific particle diameter and compounding a specific absorbefacient thereto.
CONSTITUTION: N-(2-hydroxyethyl)nicotinamide nitrate (nicorandil) having antistenocardiac action is uniformly dispersed in a base agent in the form of fine crystal particles mostly having an average particle diameter of ≥2μm, preferably ≥4μm and the dispersion is compounded with 1-20wt.% (preferably 2-15wt.%) of an absorbefacient consisting of oleic acid and/or oleyl alcohol. A preferable transcutaneous absorbability can be imparted without lowering the stability of free nicorandil and an acrylic base agent can be used in the preparation.
FUKUDA MUTSUMI
KAMINOYAMA TOMOHITO
SOGA WAKAKO
CHUGAI PHARMACEUTICAL CO LTD
Next Patent: PURIFICATION OF REACTION PRODUCT GAS CONTAINING ALLYL ACETATE